Behind our science

INSPIRED BY NATURE.
GUIDED BY SCIENCE.

Exploring the biological potential of donated full-term placental tissue.

The HPE platform

A COMPLEX RESPONSE
TO INFLAMMATION.

Plakous’s human placental extract (HPE) brings together anti-inflammatory and cell-proliferation capabilities. Our research examines how these act together to support tissue development and repair.

A COMPLEX RESPONSE<br>TO INFLAMMATION.
Our processing approach

PRESERVING WHAT
NATURE PUTS TOGETHER.

Donated tissue

Our platform begins with donated full-term placental tissue.

Biological complexity

Plakous reports preserving more than 950 proliferative, developmental and anti-inflammatory proteins and chemokines through its processing method.

Preclinical research

Growth factors are studied for their combined effects on inflammation and tissue development. These mechanisms remain under investigation.

Source: Plakous Therapeutics, Behind Our Science. Company data on file and McKinney-Aguirre et al., CMGH, 20(1), 101619.

Initial target

THE IMMATURE GUT.
AN URGENT NEED.

NEC is a serious disease affecting premature infants. Plakous’s initial focus is prevention of NEC and support for digestive development in pediatric malabsorption. These are development goals, not established clinical benefits.

Explore the pipeline
THE IMMATURE GUT.<br>AN URGENT NEED.

Research & references

McKinney-Aguirre et al. · Cellular and Molecular Gastroenterology and Hepatology · Read the publicationFull science information and references on the official website
A shared purpose

LET’S MOVE
SCIENCE FORWARD.

Start a conversation